Fortrea Holdings (FTRE) EBITDA Margin (2022 - 2026)

Fortrea Holdings (FTRE) posted EBITDA Margin of 0.53% for Q1 2026, up 74.06% on a QoQ basis from 2.06% in Q4 2025, and up 7932.0% year-over-year from 0.01% in Q1 2025.

Fortrea Holdings (FTRE) EBITDA Margin (2022 - 2026) Analysis & Trends

Fortrea Holdings' EBITDA Margin history runs 5 years deep, the most recent figure standing at 0.53% for Q1 2026.

  • Quarterly EBITDA Margin rose 7932.0% year-over-year to 0.53% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 13.14% (up 1086.0% YoY) and the FY2025 annual result came in at 32.04%, down 2604.0% from the prior year.
  • EBITDA Margin was 0.53% for Q1 2026 at Fortrea Holdings, up from 2.06% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 9.04% in Q3 2022 and bottomed at 79.86% in Q1 2025.
  • A 5-year average of 8.05% and a median of 1.64% in 2025 frame the typical range for EBITDA Margin.
  • Annual changes were most pronounced in 2025 — EBITDA Margin slumped 7421 bps — and 2026, when it soared 7932 bps.
  • Fortrea Holdings' EBITDA Margin stood at 2.85% in 2022, then sank by 219 bps to 3.38% in 2023, then sank by 136 bps to 7.98% in 2024, then soared by 74 bps to 2.06% in 2025, then jumped by 74 bps to 0.53% in 2026.
  • Business Quant data shows FTRE's EBITDA Margin at 0.53% in Q1 2026, 2.06% in Q4 2025, and 1.23% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 16.51%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 38.10%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 17.83%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 31.68%
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Fortrea Holdings 1.83 Bn 1.68 Bn 123.60 Mn -0.53%

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.53%
Dec 31, 2025 -2.06%
Sep 30, 2025 -1.23%
Jun 30, 2025 -46.50%
Mar 31, 2025 -79.86%
Dec 31, 2024 -7.98%
Sep 30, 2024 -2.67%
Jun 30, 2024 -7.68%
Mar 31, 2024 -5.65%
Dec 31, 2023 -3.38%
Sep 30, 2023 1.44%
Jun 30, 2023 4.36%
Mar 31, 2023 2.03%
Dec 31, 2022 2.85%
Sep 30, 2022 9.04%
Jun 30, 2022 8.98%